Meet our leadership team
Board Members
& Management
"I would like to thank our shareholders for their continued support and our employees all over the globe for their dedication, skills and professionalism that has brought BATM to this exciting position and will continue to move us toward growth and profitability. As always, we are committed to creating value for our shareholders in the years to come and look forward to continuing to report our progress."
Dr. Gideon Chitayat
Non-executive Chairman
Dr. Gideon Chitayat
Non-executive Chairman
Dr. Gideon Chitayat is the Chairman and CEO of GMBS Ltd, a strategic consulting firm. He has served as the Chairman of Delta Galil Industries and as a director of Milissron Shopping malls, Paz Oil Company, Teva Israel Pharmaceutical Industries, Bank Hapoalim and Israel Aircraft Industries, and has provided consultancy services in business strategy to the boards and presidents of large companies. He has also served as Adjunct Professor at Tel Aviv University, Recanati Business School. Dr. Chitayat holds a Ph.D. in Business & Applied Economics from the University of Pennsylvania, Wharton School and a Master’s in Business & Applied Economics from the Hebrew University, Jerusalem. Dr. Chitayat joined the Board of BATM in June 2010 and was appointed Chairman in January 2015. He was re-elected as a Director of the Board in December 2024.
Moti Nagar
Executive Director & CEO
Moti Nagar has been the CEO of BATM since 1 January 2023, having been the CFO since 2015. During his time at BATM, Mr. Nagar has been instrumental in driving the business' development, including leading several M&A transactions, the Group's IPO on TASE and, since his appointment as CEO, renewing the Group's strategy. Prior to BATM, Mr. Nagar held several senior positions at Deloitte, which he joined in 2005. As a Senior Manager, Mr. Nagar was responsible for handling the accounts of leading corporate clients in Israel and overseas, with companies traded on the LSE, NASDAQ and TASE as well as private businesses operating in a range of sectors. Mr. Nagar is a member of the Managing Board of the Israeli Association of Publicly Traded Companies, a non-profit organisation representing hundreds of companies listed on the Tel Aviv Stock Exchange and other stock exchanges throughout the world. Mr. Nagar graduated in Business Management and Accounting and qualified as an Israeli Certified Public Accountant (CPA, Israel) in 2008. He also holds an MBA in Financial Management from Tel Aviv University. He was re-elected as a Director of the Board in December 2024.
Dr. Zvi Marom
Founder & Non-executive Director
Dr. Zvi Marom founded BATM in 1992 and served as CEO until January 2023. A former first lieutenant in the Israeli Navy, he graduated with excellence from the officers course of the Naval Academy and with excellence from the Advanced Naval Command Course. He has a post-graduate degree in medicine from the Sackler – Gold Schlagger School of Medicine, Israel and an MSc in Electronics. Dr. Marom was the Chairman of the Hi-Tech Union of the Manufacturers’ Association of Israel until January 2021, and he now serves as the head of its quantum forum. In 2021, he received The Industry Award from the Manufacturers' Association of Israel, and in March 2024 he was awarded the Knight's Cross of the Order of Merit of Hungary. He is Chairman of ADOR Diagnostics, an associate company of BATM, and a director of Shore Capital Group plc. Dr. Marom was re-elected as a Director of BATM in December 2024.
Harel Locker
Non-executive Director & Senior Independent Director
Harel Locker has been the Chairman of the Board of Paz Oil Ltd, the leading Israeli energy company, since 2021 and was the Chairman of the Board of Israel Aerospace Industries Ltd, the leading Israeli aerospace and defence company, from 2017 to 2021. He served as the Director General of the Israeli Prime Minister’s Office and head of the Prime Minister's economic headquarters between 2011 and 2015. Mr. Locker commenced his career practicing commercial law for more than 25 years with both Tel Aviv and Wall Street, New York City, first tier law firms. He was appointed to the Board of BATM in September 2016 and his third three-year term, in accordance with Israeli law, was approved by shareholders in December 2022.
Prof. Varda Shalev
Non-executive External Director
epidemiology, medical informatics and predictive analytics in community healthcare. She was a founder and director of the Morris Kahn & Maccabi Institute for Health Research and Innovation and is an active primary care physician. She has pioneered the development of multiple disease registries to support chronic disease management, and has authored or co-authored over 200 publications in peer-reviewed medical journals.
She is a Managing Partner of Team8 Health, a medtech-focused venture capital company, and a director of Teva Pharmaceutical Industries Ltd. In addition, she is a Professor at the Tel Aviv University School of Public Health and sits on the advisory board of several med-tech businesses. She was appointed to the Board of BATM in November 2018 and her third three-year term, in accordance with Israeli law, was approved by shareholders in December 2024.
Avigdor Shafferman
Non-executive Director
Dr. Avigdor Shafferman had an established career at the Israel Institute for Biological Research, a leading governmental applied research institute specialising in the fields of biology, medicinal chemistry and environmental sciences, where he worked for almost 40 years. He is a recipient of several prestigious scientific awards and author of over 200 scientific papers. Most recently, from 1995 until his retirement in 2013, he was General Director of the organisation. Other roles have included serving as a visiting professor in the University of California, San Diego at the biology department as well as a visiting senior research scientist at various leading research institutions in the United States in various medical areas, including vaccines. Dr. Shafferman holds a Ph.D. in physical chemistry from the Hebrew University of Jerusalem.
He was re-elected as a Director of BATM in December 2024.
Shmuel Ben Zvi
Non-executive Director
Dr. Shmuel (Muli) Ben Zvi was elected as a Director of BATM in December 2024. He has extensive executive and board experience across multiple industries, including nine years as a director of Bank Leumi, the largest banking corporation in Israel, and being elected Chairman of the board in October 2023 for the final year of his tenure. At Bank Leumi, he was a member of the board’s audit, risk management, credit, technology and strategy committees. Dr. Ben Zvi is currently a director of Protalix Biotherapeutics (NYSE American: PLX) and previously of Sol-Gel Technologies (NASDAQ: SLGL) and VBL Therapeutics (NASDAQ: VBLT). From 2004 to 2014, he held a number of managerial positions at Teva Pharmaceuticals (NASDAQ and TASE: TEVA), including Vice President of Strategy and Vice President of Finance.
Ran Noy
Executive Director & CFO
Ran Noy has been the CFO of BATM since 1 February 2023, having served as VP Finance since joining the Group in 2021.
Prior to BATM, Mr. Noy spent 10 years in the finance department at ADAMA Ltd., a global agri-chem business that delivered sales of $5bn in 2021. Latterly as Financial Reporting Manager, he was responsible for ADAMA’s financial reporting to the Shenzhen Stock Exchange and the Tel Aviv Stock Exchange. He was also instrumental in ADAMA’s listing on the Shenzhen Stock Exchange via the reverse takeover of a subsidiary of ChemChina and was responsible for the financial integration of that business. Mr. Noy is an Israeli Certified Public Accountant who began his career as an auditor at EY Israel. He was re-elected as a Director of the Board in December 2024.